Vanda Pharmaceuticals (VNDA) Gross Profit Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 411.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.16% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 4.34% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 51.16% |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -5.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.60% |
| Dec 31, 2025 | -2.86% |
| Sep 30, 2025 | -3.33% |
| Jun 30, 2025 | -5.10% |
| Mar 31, 2025 | -5.16% |
| Dec 31, 2024 | -6.44% |
| Sep 30, 2024 | -10.68% |
| Jun 30, 2024 | -8.01% |
| Mar 31, 2024 | -8.06% |
| Dec 31, 2023 | -11.95% |
| Sep 30, 2023 | -13.06% |
| Jun 30, 2023 | -8.94% |
| Mar 31, 2023 | 3.02% |
| Dec 31, 2022 | 2.11% |
| Sep 30, 2022 | 3.83% |
| Jun 30, 2022 | 3.45% |
| Mar 31, 2022 | 8.58% |
| Dec 31, 2021 | 9.26% |
| Sep 30, 2021 | 12.83% |
| Jun 30, 2021 | 13.33% |
| Mar 31, 2021 | 13.21% |
| Dec 31, 2020 | 15.75% |
| Sep 30, 2020 | 13.91% |
| Jun 30, 2020 | 14.52% |
| Mar 31, 2020 | 16.47% |
| Dec 31, 2019 | 18.38% |
| Sep 30, 2019 | 18.73% |
| Jun 30, 2019 | 21.28% |
| Mar 31, 2019 | 15.98% |
| Dec 31, 2018 | 22.65% |
| Sep 30, 2018 | 26.37% |
| Jun 30, 2018 | 24.54% |
| Mar 31, 2018 | 31.58% |
| Dec 31, 2017 | 39.05% |
| Sep 30, 2017 | 37.76% |
| Jun 30, 2017 | 52.10% |